Presentation is loading. Please wait.

Presentation is loading. Please wait.

Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes  Anick Bérard, MSc, PhD, Odile Sheehy, MSc, Marie-Laure Kurzinger,

Similar presentations


Presentation on theme: "Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes  Anick Bérard, MSc, PhD, Odile Sheehy, MSc, Marie-Laure Kurzinger,"— Presentation transcript:

1 Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes 
Anick Bérard, MSc, PhD, Odile Sheehy, MSc, Marie-Laure Kurzinger, MSc, Juhaeri Juhaeri, PhD  Journal of Allergy and Clinical Immunology  Volume 138, Issue 1, Pages e7 (July 2016) DOI: /j.jaci Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig E1 Study population selection. INCS, Intranasal corticosteroids; MCM, major congenital malformation. Journal of Allergy and Clinical Immunology  , e7DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig E2 Prevalence of major congenital malformation, respiratory system malformations, and pregnancies exposed to triamcinolone or other intranasal corticosteroids per year of conception. Journal of Allergy and Clinical Immunology  , e7DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions


Download ppt "Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes  Anick Bérard, MSc, PhD, Odile Sheehy, MSc, Marie-Laure Kurzinger,"

Similar presentations


Ads by Google